| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42d2f422c32ab910d41e178f3ffd4800 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0636
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-7051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14 |
| filingDate |
2013-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76f190e711329e5a8b2deb54b7f48428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e53d0fee82ce15bb64017680cf806bd3 |
| publicationDate |
2018-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2659217-T3 |
| titleOfInvention |
Combinatorial exchange of gamma 9 delta 2 T cell receptor chain |
| abstract |
T cell receptor y9δ2 or a fragment thereof where said receptor or fragment thereof is capable of binding with a tumor cell and where said receptor comprises a T cell receptor chain and 9 comprising a CDR3 and 9 region, where the amino acid sequence of the CDR3 and 9 region corresponding to amino acid residues 122-124 of SEQ ID NO.1 is modified and a δ2 T cell receptor chain comprising a CDR3 δ2 region where the amino acid sequence of the CDR3 δ2 region corresponding to residues of amino acids 115-122 of SEQ ID NO.2 is modified, where combinations of the amino acid modifications in the T-cell receptor and 9δ2 or a fragment thereof are listed as in Table 1. |
| priorityDate |
2012-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |